Helius Therapeutics
Latest news of Helius Therapeutics. Based in Auckland, New Zealand, Helius Therapeutics has grown into one of the country’s largest and most advanced cannabis medicines producers.
-
Helius celebrates female leadership in cannabis sector
Helius Therapeutics is taking time to reflect on Suffrage Day. On 19 September 1893, New Zealand became the first nation in the world to grant women the right to vote. Now 128 years on, New Zealand has its third female Prime Minister, and almost half of its Members of Parliament are female.…
Read More » -
Helius forms advanced medicinal cannabis collaboration
New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has signed an agreement with Auckland University of Technology (AUT). It will see Helius working with AUT academics and doctoral students, researching and developing advanced medicinal cannabis products. The announcement follows Helius being issued with the local industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by…
Read More » -
Helius gains NZ’s first licence to manufacture cannabis medicines
New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by MedSafe. It allows the company to begin manufacturing locally made medicines for New Zealand patients. “This is our most significant milestone yet at Helius. The GMP Licence means Helius can…
Read More »
